hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy

BACKGROUND: The identification of early-stage colorectal cancer (CRC) with high risk of progression is one major clinical challenge, mainly due to lack of validated biomarkers. The aims of the present study were to analyze the prognostic impact of three molecular markers belonging to the ion channel...

Descripción completa

Detalles Bibliográficos
Autores principales: Muratori, Leonardo, Petroni, Giulia, Antonuzzo, Lorenzo, Boni, Luca, Iorio, Jessica, Lastraioli, Elena, Bartoli, Gianluca, Messerini, Luca, Di Costanzo, Francesco, Arcangeli, Annarosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072508/
https://www.ncbi.nlm.nih.gov/pubmed/27789963
http://dx.doi.org/10.2147/OTT.S114090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072508/
https://www.ncbi.nlm.nih.gov/pubmed/27789963
http://dx.doi.org/10.2147/OTT.S114090

Ejemplares similares